# Expanded-access use of elamipretide in a newborn with Barth syndrome: a case report.

> PubMed lists PMID 39917770 in European heart journal. Case reports as Case Reports, Journal Article, with publication-date metadata of 2025-01-22 (day precision). PeptideScanner associated the retained record with the identity slug elamipretide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-39917770-elamipretide:v1`
- Evidence domain: Literature metadata
- Date in source: 2025-02-08
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-39917770-elamipretide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-39917770-elamipretide-v1.json
- Content SHA-256: `0dfe5447855186be709324db6f5795aa12bd1243629b96279713dedf102725c5`

## Claims and source pins

### Headline

Expanded-access use of elamipretide in a newborn with Barth syndrome: a case report. ([`pubmed-observation-pmid-39917770-2025-02-08-0e4a75526b69`](#source-pubmed-observation-pmid-39917770-2025-02-08-0e4a75526b69))

### Summary

PubMed lists PMID 39917770 in European heart journal. Case reports as Case Reports, Journal Article, with publication-date metadata of 2025-01-22 (day precision). PeptideScanner associated the retained record with the identity slug elamipretide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-39917770-2025-02-08-0e4a75526b69`](#source-pubmed-observation-pmid-39917770-2025-02-08-0e4a75526b69))

### Paragraph 1

PubMed lists PMID 39917770 in European heart journal. Case reports as Case Reports, Journal Article, with publication-date metadata of 2025-01-22 (day precision). PeptideScanner associated the retained record with the identity slug elamipretide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-39917770-2025-02-08-0e4a75526b69`](#source-pubmed-observation-pmid-39917770-2025-02-08-0e4a75526b69))

### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-39917770-2025-02-08-0e4a75526b69`](#source-pubmed-observation-pmid-39917770-2025-02-08-0e4a75526b69))

## Sources

<a id="source-pubmed-observation-pmid-39917770-2025-02-08-0e4a75526b69"></a>
- **Expanded-access use of elamipretide in a newborn with Barth syndrome: a case report. · retained source version 1:2025-02-08:current:0e4a75526b6907a2c248ce693486c9a41703e57251d2f13a41f16706b5f65d87** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/39917770/) (`pubmed-observation-pmid-39917770-2025-02-08-0e4a75526b69`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "Expanded-access use of elamipretide in a newborn with Barth syndrome: a case report." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-39917770-elamipretide-v1.json SHA-256: 0dfe5447855186be709324db6f5795aa12bd1243629b96279713dedf102725c5.